Navigation Links
InterMune to Release Third Quarter Financial Results on November 3
Date:10/27/2011

BRISBANE, Calif., Oct. 27, 2011 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that it will release its third quarter 2011 financial results at the close of the U.S. markets on Thursday, November 3, 2011.  A live conference call and webcast will be hosted by InterMune at 4:30 p.m. Eastern time that same day.

Interested investors and others may participate in the conference call by dialing 888-567-5125 (U.S.) or 706-643-9223 (international), conference ID# 22885421.  A replay of the webcast and teleconference will be available on the company's website approximately three hours after the call. To access the live webcast, please log on to the company's website at www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

A telephonic replay will be available for 10 business days following the call and can be accessed by dialing 855-859-2056 (U.S.) or 404-537-3406 (international), and entering the conference ID# 22885421.  

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and fibrotic diseases.  In pulmonology, InterMune is focused on therapies for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease.  Pirfenidone, the only medicine approved worldwide for IPF, is approved for marketing by InterMune in the EU as Esbriet® and is currently in a Phase 3 clinical trial in the United States.  Pirfenidone is also approved for the treatment of IPF in Japan, where it is marketed by Shionogi & Co. Ltd. under the trade name Pirespa®.  InterMune's research programs are focused on the discovery of targeted, small-molecule therapeutics and biom
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. InterMune Announces Launch of Esbriet® (pirfenidone) in Germany
2. InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study
3. InterMune Receives European Union Approval for Esbriet® (pirfenidone)
4. InterMune Reports Fourth Quarter and Full Year 2010 Financial Results and Business Highlights
5. InterMune to Present at J.P. Morgan Healthcare Conference
6. InterMune Reports Third Quarter 2010 Financial Results
7. InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS)
8. InterMune to Release Second Quarter Financial Results on July 27
9. InterMune Announces Conference Call and Webcast to Discuss Outcome of FDA Advisory Committee
10. FDA Advisory Committee Recommends Approval of InterMunes Esbriet(R) (pirfenidone) for Idiopathic Pulmonary Fibrosis
11. InterMune Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Pirfenidone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 5, 2015 Lymphatic pump treatment (LPT) shows ... according to a new study published in The ... Researchers performed LPT on infected rats three times ... antibiotic used to treat pneumonia. After 96 hours, over ... to only 25 percent of rats who received levofloxacin ...
(Date:5/5/2015)... JERUSALEM , May 5, 2015 ... ) ( http://www.oramed.com ), a clinical-stage pharmaceutical company ... systems, announced today that the company will present ... Oppenheimer 16th Annual Israeli Conference , ,Date: ... ,Presenter:       Nadav Kidron , Chief Executive Officer ...
(Date:5/5/2015)... 2015 Research and Markets ( ... "Clinical Laboratory,Molecular Diagnostics and Genomic Testing Services ... Asia Pacific Version" report to their offering. ... growing. Clinical laboratory testing is positioned to directly ... A range of dynamic trends are pushing market ...
Breaking Medicine Technology:Lymphatic Pump Treatment Enhances Antibiotic Effectiveness for Treating Pneumonia 2Oramed to Present at Upcoming Conferences 2Oramed to Present at Upcoming Conferences 3Asia Pacific Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Report 2015-2019 2
... first time, an international panel of experts has ... Laparoscopic Sleeve Gastrectomy, a rapidly growing bariatric surgical ... The panel, made up of 25 ... help the surgical community continue to improve patient ...
... The report " In-Vitro Diagnostic (IVD) Market ... Emerging Markets   -   G7, Japan & BRIC) (2011 ... and studies the major market drivers, restraints, and opportunities in ... Browse market data tables and in-depth TOC ...
Cached Medicine Technology:International Panel of Leading Bariatric Surgeons Reaches Consensus on Optimal Techniques for Laparoscopic Sleeve Gastrectomy 2MarketsandMarkets: Global In-Vitro Diagnostic (IVD) Market Expected to Reach $64 Billion by 2016 2MarketsandMarkets: Global In-Vitro Diagnostic (IVD) Market Expected to Reach $64 Billion by 2016 3
(Date:5/5/2015)... year, PolyU researchers garnered two Grand Prizes, two Special ... and four Silver Medals at the world-renowned event. The ... Prize and Gold Medal with the Congratulations of Jury:, ... Investigator: Dr Allan Chee-kooi CHAN, Institute of Textiles and ... the “mannequin” for many tasks involved in apparel design, ...
(Date:5/5/2015)... May 05, 2015 Information ... company serving the federal government, today announced its ... (CCSi). CCSi provides solutions exclusively to federal government ... experience in cyber security, health services, and program ... and industry-relevant credentials as a Third Party Assessment ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 The brains ... accelerated aging that correlate with slower information processing, according ... Graduate School of Public Health . , The ... with type 1 diabetes for cognitive difficulties. If progressive, ... diabetes. The study, funded by the National Institutes ...
(Date:5/5/2015)... Washington, DC (PRWEB) May 05, 2015 ... Amplify Hope Initiative, a new study aimed at determining ... disease patients. RG is an international non-profit providing rare ... genomics sequencing technology, connections to scientists and researchers, and ... or crowdfunding. , “I am excited to see how ...
(Date:5/5/2015)... 2015 Barnabas Health, the state’s largest ... a new healthy cooking video series starring celebrity chef ... Bravo’s Top Chef, teamed up with Barnabas Health to ... living. In support of the series, Barnabas Health ... videos will be showcased on social media. ...
Breaking Medicine News(10 mins):Health News:PolyU wins top prizes in Geneva’s Invention Expo 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 3Health News:PolyU wins top prizes in Geneva’s Invention Expo 4Health News:PolyU wins top prizes in Geneva’s Invention Expo 5Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 2Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 3Health News:Accelerated Brain Aging in Type 1 Diabetes Related to Cognitive Complications 4Health News:Rare Genomics Institute to Study Impact of Crowdfunding on Rare Diseases 2Health News:Barnabas Health Teams Up With Celebrity Chef Sam Talbot To Launch "Life Is Better Healthy" Cooking Video Series 2Health News:Barnabas Health Teams Up With Celebrity Chef Sam Talbot To Launch "Life Is Better Healthy" Cooking Video Series 3
... TUESDAY, Dec. 27 (HealthDay News) -- Racial and cultural factors ... Americans, despite improvements to diagnostic tools and therapies in recent ... elderly blacks are less likely to be diagnosed -- and ... 6.6 percent of elderly people in the United States have ...
... By Dennis Thompson HealthDay Reporter , TUESDAY, ... some to be extreme, a strict way of eating that ... a growing number of people are giving vegan diets a ... eating plan could be the most healthy way to live ...
... suffer from one or more of the adverse complications of ... increasing. Thus far, drugs designed to treat obesity have shown ... This is largely because we have limited understanding of the ... control. For example, while great strides have been made in ...
... HealthDay Reporter , MONDAY, Dec. 26 (HealthDay News) ... improve, Norwegian researchers have found. Although time spent in ... rule out the possibility that people with higher IQs might ... researchers noted. Now, however, "there is good evidence ...
... associated with a negative reaction to eating gluten -- ... symptoms of depression and disordered eating, even when they ... Penn State, Syracuse University and Drexel University. People ... decreased appetite, diarrhea, nausea and vomiting. The disease affects ...
... (HealthDay News) -- Quitting smoking is one of the ... than done, with six of 10 smokers requiring multiple ... American Lung Association. However, preparing a quit-smoking plan ... smoking is the single most important step smokers can ...
Cached Medicine News:Health News:Racial Disparities Seem to Persist in Depression Diagnosis 2Health News:The Mainstreaming of Vegan Diets 2Health News:The Mainstreaming of Vegan Diets 3Health News:The Mainstreaming of Vegan Diets 4Health News:More Schooling Might Raise IQ 2Health News:More Schooling Might Raise IQ 3Health News:Women with celiac disease suffer from depression, disordered eating 2Health News:Women with celiac disease suffer from depression, disordered eating 3Health News:How to Make Your Quit-Smoking Resolution Stick 2
Glucose tubes contain an anti-coagulant and a stabiliser. The tubes are ideal for glucose and lactate determinations....
...
BD Vacutainer® Specialty Tubes - Trace Element - Plastic...
... The inner wall of the serum tube ... these particles activate the coagulation process. Serum ... in the base of the tube; during ... between the serum and the blood cells. ...
Medicine Products: